Diagnostic Imaging (12/12) reported that research suggests that “digital breast tomosynthesis (DBT) in cancer screening significantly decreases recall rate (RR) and finds more cancers than 2D mammography.” The findings were published in Radiology.
MedPage Today (12/11, Bankhead) reports on research that highlights the importance of early treatment in breast cancer. According to MedPage, “The survival odds for women with early breast cancer declined by almost 10% for every 30-day delay in surgery beyond the first 30 days after diagnosis.” The analysis, published in JAMA Oncology, used data from two large-scale databases: NCI’s Surveillance, Epidemiology, and End Results and the National Cancer Data Base.
Aunt Minnie (12/8, Yee) reports, in continuing coverage, that “women with a history of a false-positive screening mammogram have a nearly 40% increased risk of breast cancer for at least a decade afterward,” a study published online Dec. 2 in the journal Cancer Epidemiology, Biomarkers and Prevention suggests. Researchers arrived at that conclusion after examining data on some “2.2 million screening mammograms performed in 1.3 million women.”